Two new secondary metabolites isolated from Avena sativa L. (Oat) seedlings and their effects on osteoblast differentiation. Issue 14 (15th July 2020)

• Record Type: Journal Article
• Authors: Woo, So-Yeun; Lee, Kwang-Sik; Shin, Hye-Lim; Kim, Shin-Hye; Lee, Mi-Ja; Young Kim, Hyun; Ham, Hyeonmi; Lee, Dong-Jin; Choi, Sik-Won; Seo, Woo Duck
• Is Part Of: Bioorganic & medicinal chemistry letters. Volume 30:Issue 14(2020)
• Publication Date: 2020-07-15
• Subjects: Seedlings -- Avena sativa L. -- Oat -- Osteoporosis -- Osteoblast -- Alkaline phosphatase (ALP) activity; Bioorganic chemistry -- Periodicals; Pharmaceutical chemistry -- Periodicals; 572
• DOI: 10.1016/j.bmcl.2020.127250
• Languages: English
• ISSNs: 0960-894X

Abstract

Graphical abstract: Abstract: Seedlings of natural crops are valuable sources of pharmacologically active phytochemicals. In this study, we aimed to identify new active secondary metabolites in Avena sativa L. (oat) seedlings. Two new compounds, avenafuranol (1 ) and diosgenoside (2 ), along with eight known compounds (3 –10 ) were isolated from the A. sativa L. seedlings. Their chemical structures were elucidated via 1D and 2D NMR spectroscopy, high-resolution ESIMS, IR spectroscopy, optical rotation analysis, and comparisons with the reported literature. The effect of each isolated compound on alkaline phosphatase (ALP) activity for osteoblast differentiation induced by bone morphogenetic protein-2 (BMP-2) was investigated using the C2C12 immortal mouse myoblast cell line. Compounds 1, 4, 6, 8, and 9 induced dose-dependent increases in ALP expression relative to ALP expression in cells treated with only BMP-2, and no cytotoxicity was observed. These results suggest that A. sativa L. seedlings are a natural source of compounds that may be useful for preventing bone disorders.